Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study

被引:1
作者
Naderian, Mohammadreza [1 ,2 ]
Kolahdoozan, Shadi [1 ]
Sharifi, Amir Sina [1 ]
Garmaroudi, Gholamreza [3 ]
Yaseri, Mehdi [4 ]
Poustchi, Hossein [1 ]
Sohrabpour, Amir Ali [1 ]
机构
[1] Univ Tehran Med Sci, Digest Dis Res Inst, Liver & Pancreatobiliary Dis Res Ctr, Tehran, Iran
[2] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, Tehran, Iran
[3] Univ Tehran Med Sci, Sch Publ Hlth, Hlth Educ & Promot, Tehran, Iran
[4] Univ Tehran Med Sci, Dept Epidemiol & Biostat, Tehran, Iran
关键词
Cut-off; lean; metabolic syndrome X; Non-alcoholic fatty liver disease; non-obese; RISK-FACTORS; INSULIN-RESISTANCE; ADULT-POPULATION; ADIPOSE-TISSUE; NORMAL-WEIGHT; VISCERAL FAT; NONOBESE; OBESITY; STEATOHEPATITIS; OVERWEIGHT;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Recent data has proven that the WHO (world health organization) cut-off for obesity is not applicable to the Asian population. This study aims to estimate the prevalence of lean NAFLD (non-alcoholic fatty liver disease) in the capital of Iran and extract probable predictors for this growing heath issue in this population. Methods: This is a population-based cross-sectional study on apparently healthy subjects over 18 years of age. The participants were interviewed for baseline demographic and clinical information. They were subsequently referred for physical examination and blood sampling. NAFLD was diagnosed using abdominal ultrasonography by a single expert radiologist. Results: Of 927 eligible participants who entered the study, 314 were lean; BMI (body mass index) <25 kg/m(2). The prevalence of NAFLD was 17.52% (95% Exact CI: 13.48%-22.18%). BMI, SBP (systolic blood pressure), DBP (diastolic blood pressure), total cholesterol, HDL (high-density lipoprotein), LDL (low-density lipoprotein) and triglyceride were significantly different in patients with NAFLD. In the final multiple analysis, higher levels of triglyceride, upper SBP and higher BMI even in the range of less than 25 kg/m2 were independent predictors of NAFLD in lean participants. In lean participants with more components of metabolic syndrome, the prevalence of NAFLD increased significantly (all P < 0.01). BMI cut-offs in men and women along with waist circumference cut-off in men could significantly predict the presence of NAFLD in lean patients. After comparing these values, McNemar test showed that BMI cut-offs are more robust than waist circumference cut-offs for predicting the presence of NAFLD in lean subjects (P < 0.01). Conclusion: The prevalence of NAFLD in lean subjects in a sample of Iranian population is 17.52%. Hypertriglyceridemia, higher SBP, and higher BMI especially over 23.2 are independent factors associated with the presence of NAFLD in lean subjects.
引用
收藏
页码:211 / 217
页数:7
相关论文
共 50 条
  • [31] Association and Diagnostic Value of TyG-BMI for Hyperuricemia in Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study
    Li, Haitao
    Gao, Ge
    Xu, Zhikai
    Zhao, Lihua
    Xing, Yuling
    He, Jianqiu
    Gao, Yu
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 4663 - 4673
  • [32] Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes
    Targher, Giovanni
    Bertolini, Lorenzo
    Padovani, Roberto
    Rodella, Stefano
    Zoppini, Giacomo
    Pichiri, Isabella
    Sorgato, Claudia
    Zenari, Luciano
    Bonora, Enzo
    JOURNAL OF HEPATOLOGY, 2010, 53 (04) : 713 - 718
  • [33] Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease
    El Hadi, Hamza
    Di Vincenzo, Angelo
    Vettor, Roberto
    Rossato, Marco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
  • [34] Genetics of non-alcoholic fatty liver disease and associated metabolic disorders
    Hernaez, Ruben
    AVANCES EN DIABETOLOGIA, 2011, 27 (06): : 186 - 197
  • [35] Effect of Adult Weight Gain on Non-Alcoholic Fatty Liver Disease and Its Association with Anthropometric Parameters in the Lean Japanese Population
    Tanaka, Sho
    Fujishiro, Midori
    Watanabe, Kentaro
    Imatake, Kazuhiro
    Suzuki, Yasuyuki
    Abe, Masanori
    Ishihara, Hisamitsu
    Tani, Shigemasa
    DIAGNOSTICS, 2020, 10 (11)
  • [36] Prevalence of Non-Alcoholic Fatty Liver Disease and Its Predictors in North of Iran
    Amirkalali, Bahareh
    Poustchi, Hossein
    Keyvani, Hossein
    Khansari, Mahmood Reza
    Ajdarkosh, Hossein
    Maadi, Mansooreh
    Sohrabi, Masoud Reza
    Zamani, Farhad
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2014, 43 (09) : 1275 - 1283
  • [37] Association between homocysteine and non-alcoholic fatty liver disease in Chinese adults: a cross-sectional study
    Haijiang Dai
    Weijun Wang
    Xiaohong Tang
    Ruifang Chen
    Zhiheng Chen
    Yao Lu
    Hong Yuan
    Nutrition Journal, 15
  • [38] Association of weight-adjusted-waist index with non-alcoholic fatty liver disease and liver fibrosis: a cross-sectional study based on NHANES
    Hu, Qinggang
    Han, Kexing
    Shen, Jiapei
    Sun, Weijie
    Gao, Long
    Gao, Yufeng
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [39] An examination of eating behavior in patients with non-alcoholic fatty liver disease: A cross-sectional study in a Japanese population
    Sugiyama, Hiroki
    Kobayashi, Yukiko
    Wada, Sayori
    Ueda, Miho
    Shima, Takatomo
    Suzuki, Taro
    Sumida, Yoshio
    Aoi, Wataru
    Naito, Yuji
    Kuwahata, Masashi
    HUMAN NUTRITION & METABOLISM, 2022, 28
  • [40] The Impact of Vitamin D in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Patients with Morbid Obesity
    Borges-Canha, Marta
    Neves, Joao Sergio
    Mendonca, Fernando
    Silva, Maria Manuel
    Costa, Claudia
    Cabral, Pedro M.
    Guerreiro, Vanessa
    Lourenco, Rita
    Meira, Patricia
    Salazar, Daniela
    Ferreira, Maria Joao
    Pedro, Jorge
    Leite, Ana Rita
    von-Hafe, Madalena
    Vale, Catarina
    Viana, Sara
    Sande, Ana
    Belo, Sandra
    Lau, Eva
    Freitas, Paula
    Carvalho, Davide
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 487 - 495